User Posts: Diane Caldwell
0
Correlation Between Plasma Ceramides and Diabetes Progression: A Study from the Diabetes Prevention Program and Outcomes Study (DPPOS) 1812-LB
0

Reading RoadmapCorrelation Between Plasma Ceramides and Diabetes Progression: A Study from the Diabetes Prevention Program and Outcomes Study (DPPOS) ...

0
A One-Year Study on the Enhancement of Diabetic Retinopathy and Type 2 Diabetes Mellitus Remission through Digital Twin Technology: 1811-LB
0

Reading RoadmapA One-Year Study on the Enhancement of Diabetic Retinopathy and Type 2 Diabetes Mellitus Remission through Digital Twin Technology: 1811-LBKey ...

0
1810-LB: Evaluating the Precision of Automated Pupillometry in Diabetic Retinopathy Detection
0

Reading Roadmap1810-LB: Evaluating the Precision of Automated Pupillometry in Diabetic Retinopathy DetectionKey TakeawaysIntroduction: The Potential of ...

0
The Varied Association of Glycemic Indicators with Cardiovascular Imaging and Outcomes in Prolonged Type 1 Diabetes: A Study of 180-OR
0

Reading RoadmapThe Varied Association of Glycemic Indicators with Cardiovascular Imaging and Outcomes in Prolonged Type 1 Diabetes: A Study of 180-ORKey ...

0
1808-LB: How NIK-Mediated Microglia Polarization Leads to Endothelial Dysfunction in Diabetic Retinopathy
0

Reading Roadmap1808-LB: Unraveling the Role of NIK-Mediated Microglia Polarization in Endothelial Dysfunction and Diabetic RetinopathyKey ...

0
1807-LB: Analyzing Differences in Foot Neuro Activity between Normal and Diabetic Patients
0

Reading Roadmap1807-LB: Analyzing Differences in Foot Neuro Activity between Normal and Diabetic PatientsKey TakeawaysIntroduction: Unraveling the Complexities ...

0
Enhancing Sensory Function and Reversing Type 2 Diabetes with Digital Twin Technology: A One-Year Research Study
0

Reading RoadmapEnhancing Sensory Function and Reversing Type 2 Diabetes with Digital Twin Technology: A One-Year Research StudyKey TakeawaysIntroduction: The ...

0
1805-LB: Reducing Niacin-Triggered Skin Flushing—A Possible Supplementary Diagnostic Tool for Diabetic Peripheral Neuropathy
0

Reading Roadmap1805-LB: Reducing Niacin-Triggered Skin Flushing—A Possible Supplementary Diagnostic Tool for Diabetic Peripheral NeuropathyKey ...

0
1804-LB: Negative Correlation Between Serum Spexin Levels and Peripheral Neuropathy, Sensory Pain in Type 2 Diabetes Patients
0

Reading Roadmap1804-LB: The Intriguing Link Between Serum Spexin Levels and Peripheral Neuropathy in Type 2 Diabetes PatientsKey TakeawaysIntroduction: ...

0
1803-LB: Enhancing Diabetic Foot Ulcer Treatment through Electrochemical Skin Conductance
0

Reading Roadmap1803-LB: Enhancing Diabetic Foot Ulcer Treatment through Electrochemical Skin ConductanceKey TakeawaysIntroduction: The Potential of ...

0
783-P: Effectiveness of GLP-1RA Based on Type 2 Diabetes Phenotypes – A Single-Center Retrospective Analysis
0

Reading Roadmap783-P: Effectiveness of GLP-1RA Based on Type 2 Diabetes Phenotypes - A Single-Center Retrospective AnalysisKey TakeawaysIntroduction: ...

0
782-P: The IDEAL Randomized Controlled Trial – Deintensification of Insulin Therapy with iGlarLixi
0

Reading Roadmap782-P: The IDEAL Randomized Controlled Trial - Deintensification of Insulin Therapy with iGlarLixiKey TakeawaysIntroduction: Unpacking the IDEAL ...

0
Switching to iGlarLixi from Twice-Daily Premixed Insulin: Efficacy, Safety, and Impact on Type 2 Diabetes – A Subanalysis of the Soli-SWITCH Study
0

Reading RoadmapSwitching to iGlarLixi from Twice-Daily Premixed Insulin: Efficacy, Safety, and Impact on Type 2 Diabetes - A Subanalysis of the Soli-SWITCH ...

0
780-P: Transitioning to iGlarLixi from Premixed Insulins: A Study on Effectiveness and Safety for Type 2 Diabetes Patients
0

Reading Roadmap780-P: Transitioning to iGlarLixi from Premixed Insulins: A Study on Effectiveness and Safety for Type 2 Diabetes PatientsKey ...

0
Deep Learning Assisted Quantification of Islets for Type 1 Diabetes: A 77-PUB Study
0

Reading RoadmapDeep Learning Assisted Quantification of Islets for Type 1 Diabetes: A 77-PUB StudyKey TakeawaysIntroduction: The Intersection of Deep Learning ...

0
The Relationship Between Time in Range and Glucagon/C-Peptide Index Ratio in Type 2 Diabetes Patients: A Study from 77-OR
0

Reading RoadmapThe Relationship Between Time in Range and Glucagon/C-Peptide Index Ratio in Type 2 Diabetes Patients: A Study from 77-ORKey ...

0
779-P: Examining Clinical Traits and Treatment Trends of GLP-1RA Users in a U.S. EHR and Claims Linked Database
0

Reading Roadmap779-P: A Comprehensive Analysis of Clinical Traits and Treatment Trends of GLP-1RA Users in a U.S. EHR and Claims Linked DatabaseKey ...

0
778-P: Alterations in HbA1c Levels in Type 1 Diabetics Using GLP-1: Insights from the T1D Exchange QI Initiative
0

Reading Roadmap778-P: Alterations in HbA1c Levels in Type 1 Diabetics Using GLP-1: Insights from the T1D Exchange QI InitiativeKey TakeawaysIntroduction: ...

0
Determining Factors for Choosing GLP1RA over SGLT2i in Type 2 Diabetes Patients with Atherosclerotic Cardiovascular Disease: A Study on 777-P
0

Reading RoadmapDetermining Factors for Choosing GLP1RA over SGLT2i in Type 2 Diabetes Patients with Atherosclerotic Cardiovascular Disease: A Study on 777-PKey ...

0
HM15275: A New Long-Acting GLP-1/GIP/GCG Triple Agonist Demonstrates Promising Weight Loss and Glycemic Control in Animal Studies
0

Reading RoadmapHM15275: A New Long-Acting GLP-1/GIP/GCG Triple Agonist Shows Potential in Weight Loss and Glycemic ControlKey TakeawaysIntroduction: A New Hope ...

0
775-P: Impact of Dietary Habits on the One-Year Therapeutic Outcomes of GLP-1 Receptor Agonists
0

Reading Roadmap775-P: Impact of Dietary Habits on the One-Year Therapeutic Outcomes of GLP-1 Receptor AgonistsKey TakeawaysIntroduction: Unraveling the ...

0
774-P: The Effect of Recent GLP-1 RAs on HbA1c Levels in American Adults with Type 2 Diabetes – A Comprehensive Population-Based Time-Series Study
0

Reading Roadmap774-P: The Effect of Recent GLP-1 RAs on HbA1c Levels in American Adults with Type 2 Diabetes - A Comprehensive Population-Based Time-Series ...

0
773-P: Patterns in Obesity Medication Uptake following Tirzepatide Approval in Non-Type 2 Diabetic Adults
0

Reading Roadmap773-P: Patterns in Obesity Medication Uptake following Tirzepatide Approval in Non-Type 2 Diabetic AdultsKey TakeawaysIntroduction: The Rising ...

0
772-P: Evaluating the Risk of Pancreatitis and Biliary Disease in Adults with Type 2 Diabetes and Low to Moderate CV Risk Using GLP1RA
0

Reading Roadmap772-P: Evaluating the Risk of Pancreatitis and Biliary Disease in Adults with Type 2 Diabetes and Low to Moderate CV Risk Using GLP1RAKey ...

0
771-P: Effectiveness of Oral GLP-1 Receptor Agonist CT-996 in Human GLP-1 Receptor Knockin Mice and Obese Cynomolgus Monkeys
0

Reading Roadmap771-P: Effectiveness of Oral GLP-1 Receptor Agonist CT-996 in Human GLP-1 Receptor Knockin Mice and Obese Cynomolgus MonkeysKey ...

0
1903-LB: Analyzing the Glycemic Impact and Timing of Bolus Dose in Real-World Scenarios Using the Tempo Platform
0

Reading Roadmap1903-LB: Analyzing the Glycemic Impact and Timing of Bolus Dose in Real-World Scenarios Using the Tempo PlatformKey TakeawaysIntroduction: The ...

0
1913-LB: A 6-Month Analysis of the Bigfoot Unity Real World Study (BURST) Reveals Glycemic and Psychosocial Advantages
0

Reading Roadmap1913-LB: A 6-Month Analysis of the Bigfoot Unity Real World Study (BURST) Reveals Glycemic and Psychosocial AdvantagesKey TakeawaysIntroduction: ...

0
1912-LB: Measuring the Environmental Impact of Diabetes Devices in the U.S
0

Reading Roadmap1912-LB: Measuring the Environmental Impact of Diabetes Devices in the U.SKey TakeawaysIntroduction: The Environmental Footprint of Diabetes ...

0
1911-LB: Creating a Continuous Glucose Monitoring Knowledge Assessment for Non-Endocrinologists
0

Reading Roadmap1911-LB: Creating a Continuous Glucose Monitoring Knowledge Assessment for Non-EndocrinologistsKey TakeawaysIntroduction: The Need for a CGM ...

0
Creating and Validating a Social Risk Assessment Instrument for Type 2 Diabetes Adults
0

Reading RoadmapCreating and Validating a Social Risk Assessment Instrument for Type 2 Diabetes AdultsKey TakeawaysIntroduction: The Need for a Social Risk ...

0
1909-LB: Type 2 Diabetes Patients’ Choices in Continuous Glucose Monitoring Devices – A Discrete Choice Experiment Study
0

Reading Roadmap1909-LB: Type 2 Diabetes Patients' Choices in Continuous Glucose Monitoring Devices - A Discrete Choice Experiment StudyKey ...

0
526-P: Factors Contributing to Extended Hospitalization in Diabetic Foot Infection Patients: A Retrospective Study in a Specialized Unit
0

Reading Roadmap526-P: Factors Contributing to Extended Hospitalization in Diabetic Foot Infection Patients: A Retrospective Study in a Specialized UnitKey ...

0
525-P: Pilot Study on the Application of Remote Thermovisual Monitoring System in High-Risk Patients
0

Reading Roadmap525-P: A Revolutionary Approach to Patient MonitoringKey TakeawaysIntroduction: The Future of Patient MonitoringThe 525-P Remote Thermovisual ...

0
524-P: Potential of Diabetic Foot Ulcer Dressings as a Source of Predictive Biomarkers for Healing Progress
0

Reading Roadmap524-P: The Potential of Diabetic Foot Ulcer Dressings as a Source of Predictive Biomarkers for Healing ProgressKey TakeawaysIntroduction: ...

0
523-P: Identifying Proteomic Indicators for the Healing Duration of Diabetic Foot Ulcers
0

Reading Roadmap523-P: Identifying Proteomic Indicators for the Healing Duration of Diabetic Foot UlcersKey TakeawaysIntroduction: The Role of Proteomics in ...

0
522-P: Comparative Study of Atorvastatin Metabolites and Rosuvastatin in Inhibiting Lipoprotein(a) Oxidation under High Glucose Conditions In Vitro
0

Reading Roadmap522-P: Comparative Study of Atorvastatin Metabolites and Rosuvastatin in Inhibiting Lipoprotein(a) Oxidation under High Glucose Conditions In ...

0
521-P: Correlation of Liver Steatosis and TyG Index Among Healthy Korean Adults
0

Reading Roadmap521-P: Correlation of Liver Steatosis and TyG Index Among Healthy Korean AdultsKey TakeawaysIntroduction: Unveiling the ConnectionUnderstanding ...

0
520-P: Correlation Between Plasma Sphingolipid Profiles, Lipoproteins, and Adiposity Levels
0

Reading Roadmap520-P: Unraveling the Correlation Between Plasma Sphingolipid Profiles, Lipoproteins, and Adiposity LevelsKey TakeawaysIntroduction: The ...

0
Evaluating the Impact of Therapeutic Education on Dietary Practices in Pregnant Women with Gestational Diabetes: A 51-PUB Study
0

Reading RoadmapEvaluating the Impact of Therapeutic Education on Dietary Practices in Pregnant Women with Gestational Diabetes: A 51-PUB StudyKey ...

0
51-OR: Lack of Vascular Sorbs2 Poses Independent Risk for Vascular Complications in Diabetic Patients
0

Reading Roadmap51-OR: The Hidden Risk of Vascular Complications in Diabetic Patients Due to Lack of Vascular Sorbs2Key TakeawaysIntroduction: Unveiling the ...

0
519-P: Correlation Between Blood Sphingolipids Levels and Blood Sugar in Non-Diabetic Individuals
0

Reading Roadmap519-P: Unraveling the Correlation Between Blood Sphingolipids Levels and Blood Sugar in Non-Diabetic IndividualsKey TakeawaysIntroduction: ...

0
518-P: Impact of Advanced Glycation End Products on HDL Particles’ Cholesterol Efflux Capacity in Newly Diagnosed Type 1 Diabetes (InLipoDiab1 Study)
0

Reading Roadmap518-P: Impact of Advanced Glycation End Products on HDL Particles' Cholesterol Efflux Capacity in Newly Diagnosed Type 1 Diabetes (InLipoDiab1 ...

0
517-P: The Effect of Dietary Fatty Acids and Metabolic Health on Post-Meal Endocannabinoidome Mediators
0

Reading Roadmap517-P: The Effect of Dietary Fatty Acids and Metabolic Health on Post-Meal Endocannabinoidome MediatorsKey TakeawaysIntroduction: Unraveling the ...

0
516-P: Changes in Triglyceride Profile Due to High-Fat Diet: Reduced SCD Activity and n-3 Fatty Acids Depletion
0

Reading Roadmap516-P: Changes in Triglyceride Profile Due to High-Fat Diet: Reduced SCD Activity and n-3 Fatty Acids DepletionKey TakeawaysIntroduction: The ...

0
515-P: Examining the Relationship Between Age and Circulating Sphingolipid Species in a Normoglycemic Population: A Study
0

Reading Roadmap515-P: Examining the Relationship Between Age and Circulating Sphingolipid Species in a Normoglycemic Population: A StudyKey ...

0
513-P: Long-Term Decrease in Harmful Lipoproteins Following Minor Weight Loss in the POUNDS Lost Study
0

Reading Roadmap513-P: Long-Term Decrease in Harmful Lipoproteins Following Minor Weight Loss in the POUNDS Lost StudyKey TakeawaysIntroduction: The Impact of ...

0
512-P: Impact of Residual Cholesterol on the Development of Diabetes Mellitus
0

Reading Roadmap512-P: Impact of Residual Cholesterol on the Development of Diabetes MellitusKey TakeawaysIntroduction: Unraveling the Cholesterol-Diabetes ...

0
511-P: The Connection Between Serum Tsukushi and HDL Dysfunction in Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
0

Reading Roadmap511-P: The Connection Between Serum Tsukushi and HDL Dysfunction in Type 2 Diabetes and Nonalcoholic Fatty Liver DiseaseKey ...

0
510-P: The Link Between Residual Cholesterol, Triglyceride-Rich Lipoproteins, Insulin Resistance, and Subclinical Inflammation in Young People and Adolescents
0

Reading Roadmap510-P: The Link Between Residual Cholesterol, Triglyceride-Rich Lipoproteins, Insulin Resistance, and Subclinical Inflammation in Young People ...

0
High-Risk Cohort Study: The Impact of Maternal Apolipoprotein C3 on Diabetes During Pregnancy
0

Reading RoadmapHigh-Risk Cohort Study: The Impact of Maternal Apolipoprotein C3 on Diabetes During PregnancyKey TakeawaysIntroduction: Unraveling the ...

0
Metabolic Dysfunction Reduces DDT Expression in the Heart, Worsening Post-Ischemic Myocardial Injury
0

Reading RoadmapMetabolic Dysfunction and Its Impact on DDT Expression in the Heart: A Deep Dive into Post-Ischemic Myocardial InjuryKey TakeawaysIntroduction: ...

0
509-P: Nr5a1 Nuclear Receptor’s Role in Adipogenesis as a New Transcriptional Regulator of PPARgamma
0

Reading Roadmap509-P: Nr5a1 Nuclear Receptor's Role in Adipogenesis as a New Transcriptional Regulator of PPARgammaKey TakeawaysIntroduction: Unraveling the ...

0
508-P: Increased Lactate Clearance Indicated by Metabolic Phenome of Hepatoprotective HSD17B13 Splice Variant rs72613567:TA
0

Reading RoadmapDecoding the Metabolic Phenome of Hepatoprotective HSD17B13 Splice Variant rs72613567:TAKey TakeawaysIntroduction: Unraveling the Metabolic ...

0
507-P: The Role of Long Noncoding RNA hLMR1 in Regulating Lipogenesis Specifically in the Human Liver
0

Reading Roadmap507-P: The Role of Long Noncoding RNA hLMR1 in Regulating Lipogenesis Specifically in the Human LiverKey TakeawaysIntroduction: Unraveling the ...

0
506-P: The Role of Branched-Chain Amino Acids in Cardiovascular Disease Progression Through Triglyceride Metabolism and mTOR/SREBP-1/Betatrophin Pathway Activation
0

Reading Roadmap506-P: The Role of Branched-Chain Amino Acids in Cardiovascular Disease Progression Through Triglyceride Metabolism and mTOR/SREBP-1/Betatrophin ...

0
Correlation between FreeStyle Libre Use and Blood Sugar Levels in Type 2 Diabetes Patients on Basal Insulin and GLP-1RAs Treatment
0

Reading RoadmapCorrelation between FreeStyle Libre Use and Blood Sugar Levels in Type 2 Diabetes Patients on Basal Insulin and GLP-1RAs TreatmentKey ...

0
1916-LB: Incidence, Traits, and Long-Term Complications in Type 1 Diabetes Patients with Fast-Glycator Phenotype
0

Reading Roadmap1916-LB: Incidence, Traits, and Long-Term Complications in Type 1 Diabetes Patients with Fast-Glycator PhenotypeKey TakeawaysIntroduction: ...

0
1915-LB: Exploring the Effect of Glycemic Fluctuations on the Correlation between Time in Range (TIR) and Glucose Management Indicator (GMI) in Type 2 Diabetes Patients with TIR Above 70%
0

Reading Roadmap1915-LB: Unraveling the Impact of Glycemic Fluctuations on the Correlation between Time in Range (TIR) and Glucose Management Indicator (GMI) in ...

0
1914-LB: The Enhanced A1C Improvement in Type 2 Diabetes Patients Not on Insulin Therapy through the Combined Use of CGM and Antidiabetes Drugs
0

Reading Roadmap1914-LB: The Enhanced A1C Improvement in Type 2 Diabetes Patients Not on Insulin Therapy through the Combined Use of CGM and Antidiabetes ...

0
869-P: Gastrin Lowers Type 1 Diabetes Occurrence by Decreasing Inflammation and Maintaining ß-Cell Mass in Animal Study
0

Reading Roadmap869-P: Gastrin Lowers Type 1 Diabetes Occurrence by Decreasing Inflammation and Maintaining ß-Cell Mass in Animal StudyKey ...

0
Phase 2 Trial: Evaluating the Efficacy and Safety of Crisugabalin and Acetyl-Levo-Carnitine for Diabetic Peripheral Neuropathic Pain in Chinese Patients
0

Reading RoadmapPhase 2 Trial: Evaluating the Efficacy and Safety of Crisugabalin and Acetyl-Levo-Carnitine for Diabetic Peripheral Neuropathic Pain in Chinese ...

0
867-P: The BESTMED Study: Evaluating Cardiovascular Results in Patients Starting a Second Diabetes Drug Post-Metformin
0

Reading Roadmap867-P: The BESTMED Study: Evaluating Cardiovascular Results in Patients Starting a Second Diabetes Drug Post-MetforminKey TakeawaysIntroduction: ...

0
Evaluating the Applicability of FIDELIO-DKD and FIGARO-DKD Criteria to Type 2 Diabetic Canadians in a Community Endocrinology Context
0

Reading RoadmapEvaluating the Applicability of FIDELIO-DKD and FIGARO-DKD Criteria to Type 2 Diabetic Canadians in a Community Endocrinology ContextKey ...

0
Metformin’s Impact on Insulin Dosage, Visceral Fat, and GDF15 in Type 1 Diabetes: Findings from a 26-Week Double-Blind Placebo-Controlled Trial (INTIMET)
0

Reading RoadmapMetformin's Impact on Insulin Dosage, Visceral Fat, and GDF15 in Type 1 Diabetes: Findings from a 26-Week Double-Blind Placebo-Controlled Trial ...

0
864-P: GLY-200, an Oral Drug, Reduces Appetite and Food Intake while Increasing Satiation in Type 2 Diabetes Patients
0

Reading Roadmap864-P: GLY-200, an Oral Drug, Reduces Appetite and Food Intake while Increasing Satiation in Type 2 Diabetes PatientsKey TakeawaysIntroduction: ...

0
863-P: Enhanced Kidney Function through Genetically Proxied GLP-1 Receptor Agonism: A Mendelian Randomization Study
0

Reading Roadmap863-P: Enhanced Kidney Function through Genetically Proxied GLP-1 Receptor Agonism: A Mendelian Randomization StudyKey TakeawaysIntroduction: ...

0
862-P: Results of a Randomized, Double-Blind, Placebo-Controlled Trial on the Efficacy and Safety of Orlistat for Overweight/Obese Individuals with Hyperuricemia
0

Reading Roadmap862-P: A Comprehensive Analysis of Orlistat's Efficacy and Safety for Overweight/Obese Individuals with HyperuricemiaKey TakeawaysIntroduction: ...

0
861-P: Comparing the Effectiveness of Digital Intervention and Metformin in Treating Polycystic Ovary Syndrome: A Randomized Clinical Trial
0

Reading Roadmap861-P: Comparing the Effectiveness of Digital Intervention and Metformin in Treating Polycystic Ovary Syndrome: A Randomized Clinical TrialKey ...

0
860-P: Impact of Combined SGLT2 Inhibitors and GLP1 Receptor Agonists Treatment on Japanese Patients with Type 2 Diabetes and Obesity
0

Reading Roadmap860-P: Impact of Combined SGLT2 Inhibitors and GLP1 Receptor Agonists Treatment on Japanese Patients with Type 2 Diabetes and ObesityKey ...

0
The Influence of Type 2 Diabetes on Liver Transplantation Results in the US from 2007-2022: An 85-OR Study
0

Reading RoadmapThe Influence of Type 2 Diabetes on Liver Transplantation Results in the US from 2007-2022: An 85-OR StudyKey TakeawaysIntroduction: The ...

0
859-P: Successful Targeting of Hepatic Ketohexokinase by ALN-KHK, an Experimental RNA Interference Therapeutic, in a Single Ascending Dose Study on Overweight to Obese Adults
0

Reading Roadmap859-P: Successful Targeting of Hepatic Ketohexokinase by ALN-KHK, an Experimental RNA Interference Therapeutic, in a Single Ascending Dose Study ...

0
857-P: Observational Study on the Effects of Weekly Semaglutide Injections on Weight, BMI, and HbA1c Levels in Type 2 Diabetes Patients (PAUSE)
0

Reading Roadmap857-P: Observational Study on the Effects of Weekly Semaglutide Injections on Weight, BMI, and HbA1c Levels in Type 2 Diabetes Patients ...

0
856-P: Utilizing MSC-EV for the Prevention of Type 1 Diabetes
0

Reading Roadmap856-P: Utilizing MSC-EV for the Prevention of Type 1 DiabetesKey TakeawaysIntroduction: The Potential of MSC-EV in Type 1 Diabetes PreventionThe ...

0
Podocyte-Specific REDD1 Expression Induces Glomerular Pathology and Renal Dysfunction in a Rodent Diabetic Nephropathy Model
0

Reading RoadmapPodocyte-Specific REDD1 Expression: A Key Player in Diabetic NephropathyKey TakeawaysIntroduction: Unraveling the Role of REDD1 in Diabetic ...

0
191-OR: Conference on Global Agreement and Campaign to Eradicate Diabetes Discrimination
0

Reading Roadmap191-OR: Conference on Global Agreement and Campaign to Eradicate Diabetes DiscriminationKey TakeawaysIntroduction: A Global Call to ActionThe ...

0
1919-LB: Verification of GlucoseReady – A New GxP Platform for Instant CGM Data Collection
0

Reading Roadmap1919-LB: Verification of GlucoseReady - A New GxP Platform for Instant CGM Data CollectionKey TakeawaysIntroduction: A New Era in Diabetes ...

0
1918-LB: Enhanced Postoperative Glucose Management in Diabetic Liver Transplant Patients through rtCGM
0

Reading Roadmap1918-LB: Enhanced Postoperative Glucose Management in Diabetic Liver Transplant Patients through rtCGMKey TakeawaysIntroduction: The Importance ...

0
907-P: Impact of Imeglimin on Blood Sugar Control in Japanese Type 2 Diabetes Patients
0

Reading Roadmap907-P: Impact of Imeglimin on Blood Sugar Control in Japanese Type 2 Diabetes PatientsKey TakeawaysIntroduction: A New Hope for Type 2 Diabetes ...

0
906-P: Evaluating the Safety and Effectiveness of Polmacoxib in Treating Diabetes-Related Frozen Shoulder: A Prospective Randomized Control Trial
0

Reading Roadmap906-P: Evaluating the Safety and Effectiveness of Polmacoxib in Treating Diabetes-Related Frozen Shoulder: A Prospective Randomized Control ...

0
905-P: GDF15 Levels Rise Independently of Anterior Pituitary Hormone Changes in Metformin Usage
0

Reading Roadmap905-P: GDF15 Levels Rise Independently of Anterior Pituitary Hormone Changes in Metformin UsageKey TakeawaysIntroduction: Unraveling the ...

0
Improved Blood Sugar Control in Type 2 Diabetes Patients Using Combined Glimepiride/Vildagliptin/Metformin Therapy After Dual Therapy Failure
0

Reading RoadmapImproved Blood Sugar Control in Type 2 Diabetes Patients Using Combined Glimepiride/Vildagliptin/Metformin Therapy After Dual Therapy FailureKey ...

0
Improving Glycemic Control in Type 2 Diabetes Mellitus with Imeglimin: Study 903-P
0

Reading RoadmapImproving Glycemic Control in Type 2 Diabetes Mellitus with Imeglimin: An Insight into Study 903-PKey TakeawaysIntroduction: A New Hope in ...

0
The Impact of GlucoLo Plus, an Alternative Medicine, on Lipid Profile Enhancement in Type 2 Diabetes Management
0

Reading RoadmapThe Impact of GlucoLo Plus on Lipid Profile Enhancement in Type 2 Diabetes ManagementKey TakeawaysIntroduction: The Role of GlucoLo Plus in ...

0
901-P: Evaluating BMF-219, an Oral Covalent Menin Inhibitor, in Type 1 Diabetes – The COVALENT 112 Clinical Trial
0

Reading Roadmap901-P: Evaluating BMF-219, an Oral Covalent Menin Inhibitor, in Type 1 Diabetes - The COVALENT 112 Clinical TrialKey TakeawaysIntroduction: A ...

0
Evaluating the Safety and Effectiveness of Lobeglitazone in Indian Type 2 Diabetes Patients: A Multicentre, Retrospective Study (LODIAB INDIA)
0

Reading RoadmapEvaluating the Safety and Effectiveness of Lobeglitazone in Indian Type 2 Diabetes Patients: A Multicentre, Retrospective Study (LODIAB ...

0
Defining Peer Support through Key Functions: Implementation, Outcome Prediction, and Mediation of Intervention Effects in Diabetes Management in Shanghai, China
0

Reading RoadmapDefining Peer Support through Key Functions: Implementation, Outcome Prediction, and Mediation of Intervention Effects in Diabetes Management in ...

0
Long-Term Variations in Metabolic Decompensation Among Diabetes Prevention Program Outcomes Study (DPPOS) Participants: A 20-Year Analysis
0

Reading RoadmapLong-Term Variations in Metabolic Decompensation Among Diabetes Prevention Program Outcomes Study (DPPOS) Participants: A 20-Year AnalysisKey ...

0
GPSM1’s Role in Adipocyte Browning and Metabolic Health Through ER Ca 2+ -Myosin II Axis Regulation
0

Reading RoadmapGPSM1's Role in Adipocyte Browning and Metabolic Health Through ER Ca 2+ -Myosin II Axis RegulationKey TakeawaysIntroduction: Unraveling the ...

0
Enhanced Glycemic Benefits in db/db Mice with Combined Use of Mitochondrial Protonophore TLC-6740 and ACC2 Inhibitor TLC-3595 Alongside Semaglutide (SEMA)
0

Reading RoadmapEnhanced Glycemic Benefits in db/db Mice with Combined Use of Mitochondrial Protonophore TLC-6740 and ACC2 Inhibitor TLC-3595 Alongside ...

0
898-P: AAV-FGF21 Gene Therapy Prolongs Healthy Aging in Elderly Mice
0

Reading Roadmap898-P: AAV-FGF21 Gene Therapy Prolongs Healthy Aging in Elderly MiceKey TakeawaysIntroduction: The Promise of Gene Therapy for AgingThe Science ...

0
897-P: Efruxifermin’s Insulin-Sensitizing Effects Enhance Glycemic Regulation in MASH and Type 2 Diabetes Patients
0

Reading Roadmap897-P: Efruxifermin's Insulin-Sensitizing Effects Enhance Glycemic Regulation in MASH and Type 2 Diabetes PatientsKey TakeawaysIntroduction: A ...

0
896-P: First Human Trial of Duodenal Mucosal Recellularization Using Pulsed Electric Field Electroporation (ReCET) in Type 2 Diabetes Patients
0

Reading Roadmap896-P: First Human Trial of Duodenal Mucosal Recellularization Using Pulsed Electric Field Electroporation (ReCET) in Type 2 Diabetes ...

0
895-P: Global Audit on Testosterone Replacement Therapy for Hypogonadal Men with Type 2 Diabetes
0

Reading Roadmap895-P: Global Audit on Testosterone Replacement Therapy for Hypogonadal Men with Type 2 DiabetesKey TakeawaysIntroduction: Unveiling the ...

0
894-P: Observational Study on the Safety and Effectiveness of Imeglimin for Patients Intolerant to Metformin
0

Reading Roadmap894-P: Observational Study on the Safety and Effectiveness of Imeglimin for Patients Intolerant to MetforminKey TakeawaysIntroduction: A New ...

0
893-P: Efficacy of Finerenone on Type 2 Diabetes and Chronic Kidney Disease in Chinese Patients: A Real-World Study
0

Reading Roadmap893-P: Efficacy of Finerenone on Type 2 Diabetes and Chronic Kidney Disease in Chinese Patients: A Real-World StudyKey TakeawaysIntroduction: ...

0
892-P: Exploring the Possibility of Combining New Oral Insulin Sensitizers with GLP-1 Agonists
0

Reading Roadmap892-P: Exploring the Possibility of Combining New Oral Insulin Sensitizers with GLP-1 AgonistsKey TakeawaysIntroduction: The Potential of ...

0
891-P: Spleen Identified as Primary Site for Blood Glucose Absorption in BCG-Treated Type 1 Diabetes Patients via 18 F-FDG PET/CT Mapping
0

Reading Roadmap891-P: Spleen Identified as Primary Site for Blood Glucose Absorption in BCG-Treated Type 1 Diabetes Patients via 18 F-FDG PET/CT MappingKey ...

0
Ultraselective DYRK1A/B Inhibitors Enhance ß-Cell Growth and Insulin Production In Vitro and In Vivo: Study 890-P
0

Reading RoadmapUltraselective DYRK1A/B Inhibitors: A Potential Game-Changer for Diabetes TreatmentKey TakeawaysIntroduction: A New Hope for Diabetes ...

0
Glucose’s Role in Adipose Tissue Browning: The Impact of CBP/p300 and HDAC3-Mediated Reversible Acetylation of CREBZF
0

Reading RoadmapGlucose's Role in Adipose Tissue Browning: The Impact of CBP/p300 and HDAC3-Mediated Reversible Acetylation of CREBZFKey TakeawaysIntroduction: ...

0
889-P: Research on Treatment Procedure for Type 2 Diabetes
0

Reading Roadmap889-P: Research on Treatment Procedure for Type 2 DiabetesKey TakeawaysIntroduction: Unveiling the 889-P Treatment ProcedureUnderstanding the ...

User Articles: Diane Caldwell
Sorry. Author have no articles yet
User Deals: Diane Caldwell
Sorry. Author have no deals yet
Browsing All Comments By: Diane Caldwell
Diabetes Compass
Logo
Compare items
  • Cameras (0)
  • Phones (0)
Compare